Physician profile
Stephen Hightower
NPI 1972603371
$4,316.64
in general payments reported to CMS, 2019-2025
36 companies · $672 in 2025
The $672 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $827 · 2020: $332 · 2021: $677 · 2022: $636 · 2023: $687 · 2024: $486 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,759 · Education: $86.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,758.96 |
| Education | $86.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $688.48 | 2019-2025 | |
| Abbvie INC. | $346.14 | 2019-2025 | |
| Boston Scientific Corporation | $305.54 | 2019-2025 | Bulkamid, Rezum Generator |
| Coloplast Corp | $257.68 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $251.25 | 2023-2025 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $236.98 | 2021-2025 | |
| Tolmar, INC. | $221.36 | 2023-2025 | Eligard |
| Bayer Healthcare Pharmaceuticals INC. | $184.34 | 2019-2023 | |
| Accord Healthcare, INC. | $152.77 | 2022-2025 | |
| Teleflex LLC | $150.16 | 2021-2025 | Urolift |
| Myovant Sciences INC. | $138.59 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $129.07 | 2021-2025 | Pylarify |
| Janssen Biotech, INC. | $124.62 | 2021-2024 | Erleada |
| Endo Pharmaceuticals INC. | $113.58 | 2020-2023 | Xiaflex, Aveed |
| Procept Biorobotics Corporation | $98.26 | 2023-2025 | Aquabeam Robotic System |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $83.91 | 2020-2025 | Bard Urinary Drainage Bag |
| Pfizer INC. | $82.66 | 2019-2025 | |
| Endo USA, INC. | $73.53 | 2024-2025 | Xiaflex, Aveed |
| Neotract INC. | $72.70 | 2019 | |
| Myriad Genetic Laboratories, INC. | $68.36 | 2024 | Prolaris |
| Blue Earth Diagnostics | $59.06 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $54.41 | 2023 | |
| Alnylam Pharmaceuticals INC. | $44.11 | 2021 | |
| Allergan, INC. | $43.05 | 2019-2021 | |
| Acerus Pharmaceuticals Corporation | $41.82 | 2022 | |
| Antares Pharma, INC. | $40.70 | 2019-2021 | |
| 180 Medical, INC. | $35.37 | 2019 | |
| Dendreon Pharmaceuticals LLC | $32.80 | 2021 | |
| Olympus America INC. | $31.51 | 2019-2022 | |
| Cook Medical LLC | $28.47 | 2019 | |
| Ferring Pharmaceuticals INC. | $28.35 | 2019 | |
| Ethicon US, LLC | $24.93 | 2020 | |
| Curium US LLC | $22.02 | 2023 | |
| Novo Nordisk INC | $21.08 | 2024 | |
| Sagent Pharmaceuticals | $17.07 | 2025 | Glydo |
| Srs Medical Systems, INC. | $11.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Hightower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.